Suzuki, T., Tada, Y., Gladson, S., Nishimura, R., Shimomura, I., Karasawa, S., . . . West, J. (2017). Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition. Respir Res.

Suzuki, Toshio, Yuji Tada, Santhi Gladson, Rintaro Nishimura, Iwao Shimomura, Satoshi Karasawa, Koichiro Tatsumi, e James West. "Vildagliptin Ameliorates Pulmonary Fibrosis in Lipopolysaccharide-induced Lung Injury By Inhibiting Endothelial-to-mesenchymal Transition." Respir Res 2017.

Suzuki, Toshio, et al. "Vildagliptin Ameliorates Pulmonary Fibrosis in Lipopolysaccharide-induced Lung Injury By Inhibiting Endothelial-to-mesenchymal Transition." Respir Res 2017.